Lumbar fusion surgery is usually prompted by chronic back pain, and many patients receive long-term preoperative opioid analgesics. Many expect surgery to eliminate the need for opioids. We sought to determine what fraction of long-term preoperative opioid users discontinue or reduce dosage postoperatively; what fraction of patients with little preoperative use initiate long-term use; and what predicts long-term postoperative use. This retrospective cohort study included 2491 adults undergoing lumbar fusion surgery for degenerative conditions, using Oregon's prescription drug monitoring program to quantify opioid use before and after hospitalization. We defined long-term postoperative use as $4 prescriptions filled in the 7 months after hospitalization, with at least 3 occurring .30 days after hospitalization. Overall, 1045 patients received long-term opioids preoperatively, and 1094 postoperatively. Among long-term preoperative users, 77.1% continued long-term postoperative use, and 13.8% had episodic use. Only 9.1% discontinued or had short-term postoperative use. Among preoperative users, 34.4% received a lower dose postoperatively, but 44.8% received a higher long-term dose. Among patients with no preoperative opioids, 12.8% became longterm users. In multivariable models, the strongest predictor of long-term postoperative use was cumulative preoperative opioid dose (odds ratio of 15.47 [95% confidence interval 8.53-28.06] in the highest quartile). Cumulative dose and number of opioid prescribers in the 30-day postoperative period were also associated with long-term use. Thus, lumbar fusion surgery infrequently eliminated long-term opioid use. Opioid-naive patients had a substantial risk of initiating long-term use. Patients should have realistic expectations regarding opioid use after lumbar fusion surgery.
Introduction
Increased use of prescription opioids over the past 2 decades has been associated with major increases in opioid-related overdoses and addiction treatment. 28, 30 One response has been closer examination of factors leading to opioid initiation, including analgesic prescriptions after surgical procedures. 1, 7, 31 Many studies of postoperative opioid prescribing have included surgical procedures not primarily performed for chronic pain symptoms, such as cataract surgery, transurethral prostate resection, cesarean section, or thyroidectomy. 1, 7, 31 Surgical procedures for patients with chronic painful conditions, such as many orthopedic procedures, pose additional challenges because many patients receive long-term opioids before surgery.
Spine surgery, in particular, may be associated with a high risk of preoperative and persistent postoperative opioid use. 7, 23 Lumbar fusion surgery for degenerative spinal disorders is usually undertaken to treat chronic back pain, and is more invasive than decompression surgery alone. Nationally, the number of spinal fusion operations has tripled in the past 2 decades. 17 Patients considering fusion surgery often expect to discontinue opioids after surgery. For example, among patients scheduled to undergo lumbar fusion surgery for degenerative disc disease, over 90% "considered continued narcotic requirements to be neither an expected nor acceptable outcome." 8 However, recent studies find that 30% to 60% of patients receive long-term opioids after spine surgery. 4, 12, 24 Preoperative opioid use is consistently a major predictor of long-term postoperative use. 2, 4, 12 However, data on long-term opioid use after spine or other orthopedic surgery are often limited by reliance on patient selfreport, 4 continual insurance enrollment, 12, 24 or relatively small patient samples. 4, 26 For spinal fusion surgery, few data address how preoperative dosage may influence the likelihood of long-term postoperative opioid use or the ability to reduce dosage, what fraction of those with no preoperative opioid use initiate long-term use postoperatively, or how perioperative opioid management influences the likelihood of long-term postoperative use.
We used a state hospital discharge registry linked with statewide prescription drug monitoring program (PDMP) data to identify lumbar fusion operations and opioid prescription fills, regardless of insurance coverage or source of prescriptions. We addressed the following questions: (1) 
Methods
Study activities were approved by Institutional Review Boards at Oregon Health & Science University and the Public Health Division of the Oregon Health Authority, where the PDMP is housed.
Data preparation
Data were obtained from the Oregon PDMP and linked to the statewide hospital discharge registry. Preparation of the research database has been described in detail elsewhere. 15, 27 Oregon's PDMP is maintained by a commercial vendor, who uses a largely deterministic, proprietary algorithm for linking filled prescriptions for individual patients. This procedure may not always uniquely identify patients in the face of misspellings, nicknames, transposed characters, name changes, or changes in residence. An analyst at the Public Health Division therefore used probabilistic linking software (the Link King v7.1.21) to match individuals within the PDMP and between the PDMP and the hospital registry, using name, birthdate, and ZIP Code. Because of the sensitivity of opioid use, the analyst then removed all identifiers for patients, prescribers, and pharmacies.
Inclusion and exclusion of procedures
We used diagnosis-related group (DRG) codes 453, 454, 456, 459, and 460 to identify adults undergoing lumbar fusion procedures with admission dates between October 2012 and September 2013. If a patient had more than 1 eligible procedure, we counted only the first, so each patient is represented only once. These codes exclude procedures performed primarily for scoliosis, malignancy, infection, or those involving 9 or more vertebrae. Procedures in DRGs 453, 454, and 455 were labeled as "complex fusions" because they include combined anterior and posterior fusion procedures. Cases in DRGs 453, 454, and 459 are defined as having complicating conditions. We then linked operations with International Classification of Diseases version 9, Clinical Modification (ICD-9-CM) codes indicating lumbar spine diagnoses of herniated disk, probable degenerative changes, spinal stenosis, possible instability, nonspecific backache, or sequelae of previous back surgery. Only these diagnoses were included. ICD-9-CM codes were grouped into these diagnostic categories using a previously described approach. 10 These conditions are largely related to degenerative spinal changes. Because multiple diagnoses for a single patient were common, we tabulated patients according to the likely primary reason for performing a fusion procedure. For this purpose, we adapted a previously developed hierarchy, 22 classifying patients by the highest-numbered diagnosis in this list: (1) nonspecific diagnoses, (2) degenerative spinal changes, (3) herniated disk, (4) sequelae of previous surgery, (5) lumbar stenosis, and (6) possible instability (mostly spondylolisthesis).
We excluded patients younger than 18 years and those with diagnoses of fractures, inflammatory spondylopathies, cancer, or spinal infection (Fig. 1). 
Filled prescriptions
Using PDMP data, we identified outpatient opioid prescriptions filled during the 7 months before index hospitalization and 7 months after it. We used Food and Drug Administration (FDA) National Drug Codes to identify opioid prescriptions. Tramadol was not included in the PDMP during study years, and we excluded combination of buprenorphine-naloxone preparations. We used conversion reference tables from the Centers for Disease Control (CDC) to calculate morphine milligram equivalents (MMEs) for each prescription. We also identified benzodiazepine use in the 7 months before and after hospitalization.
We defined a "perioperative period" as the 30 days before and 30 days after index hospitalization. We separately examined the 180 days before and 180 days after the perioperative period. We defined short-term preoperative opioid use as any opioid prescription filled within 30 days before the index hospitalization, but with none in the previous 180 days. Short-term postoperative use was any outpatient prescription for opioids filled in the 30 days immediately after index hospitalization, but with none in the 180 days after that. Thus, short-term use meant opioids filled only in the perioperative period.
Long-term preoperative opioid use was defined as at least 4 opioid fills in the 7 months before index hospitalization, with at Figure 1 . Selection of study patients. *Forty-one patients had more than 1 procedure within the time frame; only the index procedure was retained for this study. DRG, diagnosis-related group. least 3 fills in the 180 days before the perioperative period. Longterm postoperative use was at least 4 opioid fills in the 7 months after index hospitalization, with at least 3 of those more than 30 days after hospitalization. These definitions of long-term use were consistent with a definition of 6 fills in 12 months which has been used in previous studies, and which was associated with a 7-fold increase (vs those with fewer fills) in hospitalizations with opioidrelated adverse events. 15, 25 Some patients who received opioids would not fit our definitions of short-term or long-term use. For example, a patient with 2 prescriptions before the perioperative period, or one who had a single prescription in the preoperative 30 days and a single prescription before that, would meet neither definition. We labeled such patients as having "episodic" opioid use. Our data included only outpatient prescription fills. Opioids used during inpatient care, or provided from the hospital at discharge, were not identified in our data.
The "long-term preoperative cumulative dose" was defined as the sum of all MMEs prescribed in the 180 days before the perioperative period. The "long-term postoperative cumulative dose" was defined as the sum of all MMEs filled in the 180 days after the perioperative interval. These definitions of cumulative dose excluded medications during the perioperative period, when greater analgesic doses are usually necessary and expected. A cumulative dose exceeding 16,200 MMEs in 180 days (an average of $90 MMEs/d) was defined as "high dose." 16 A change from preoperative cumulative dose to postoperative cumulative dose of $10% was considered an increase or a decrease. A change of ,10% was considered a stable dose. Changes in opioid doses were based on cumulative MMEs filled during the 180 days before and the 180 days after the perioperative interval. All definitions were established before data analysis.
Comorbid conditions
We calculated the ICD-9-CM version of the Charlson comorbidity index 14 using diagnoses recorded in the index hospital discharge record.
Analysis
Characteristics of patients who did or did not become long-term postoperative opioid users were compared with x 2 statistics, rank-sum tests, or t tests as appropriate. Independent predictors of long-term postoperative opioid use were identified using multivariable logistic regression. Candidate predictors included patient demographic characteristics, comorbidity score, surgical procedure characteristics, and features of preoperative and perioperative opioid prescribing. The final regression model included all these variables, so predictors of long-term use were adjusted for possible confounding by each of these features. To assess the impact of opioid dose on predicting long-term use, we first constructed a logistic model without dosing information, but with an indicator for whether the patient received long-term preoperative opioids. We then constructed a second logistic model incorporating preoperative and perioperative opioid dose information. The distribution of opioid doses was right skewed. Rather than identifying and removing outliers to use dose as a continuous variable, we decided to keep all patients in the study and categorize cumulative opioid doses into quartiles. This mitigates any effect of patients with very high doses and allows the relationship to vary arbitrarily in the logit (ie, does not assume linearity in the logit). Dividing into quartiles also helped to facilitate clinical understanding of the results, as opposed to determining odds ratios (ORs) for every milligram increase in dose. Regarding surgical indications, we combined the least specific diagnoses (nonspecific, miscellaneous, and degenerative changes) as a reference category, because of small numbers in the nonspecific category. Statistical tests were 2 sided and significance was defined as P , 0.05; analyses were performed using SAS v.9.3. Model fit was assessed with the Hosmer-Lemeshow statistic and the area under a receiver-operating characteristic curve (AUC) distinguishing those who exhibited long-term postoperative opioid use from those who did not.
We also conducted a sensitivity analysis using an alternative definition of long-term opioid use: at least 3 opioid fills in the 7 months before index hospitalization, with at least 2 fills in the 180 days before the perioperative period. Long-term postoperative use was at least 3 opioid fills in the 7 months after index hospitalization, with at least 2 of those more than 30 days after hospitalization. The results of this sensitivity analysis were qualitatively the same as our base case analysis and are not presented here.
Results

Patients and procedures
There were 2491 patients who underwent an eligible fusion operation and all were included. Over half (59.7%) were female, 45.8% were aged 65 years or older, and only 12.6% were younger than 45 years. Reflecting the Oregon population, 93.5% were white ( Table 1) .
Most surgical procedures (n 5 2113; 84.8%) were classified in DRG 460: "fusion without major complicating conditions." Next, most frequent (n 5 207; 8.3%) was "combined anterior and posterior fusion without complicating conditions." Overall, 6.9% of procedures were coded with complications (DRGs 453, 454, and 459). Combined anterior and posterior procedures (with or without complications) accounted for 12.9% (n 5 320).
The most common primary reason for surgery was "possible instability" (n 5 1479, 59.4%) which was mainly spondylolisthesis (n 5 1421, or 96.1% of the category). Degenerative spinal changes accounted for 12.0% (n 5 299). Spinal stenosis primarily accounted for 298 procedures (12.0%) and herniated disk for 256 cases (10.3%). There were 133 cases (5.3%) with diagnosis codes indicating sequelae of previous back surgery, and the remainder (1.0%) fell into miscellaneous or nonspecific diagnostic categories ( Table 1) .
Opioid use
More patients received long-term opioids after spinal fusion surgery than before. Overall, 1045 patients received preoperative long-term opioids, and 1094 received long-term postoperative opioids. Among patients receiving long-term preoperative opioids, 806 (77.1%) continued long-term postoperative use, and 144 (13.8%) had episodic postoperative use. Only 95 (9.1%) discontinued opioids or had short-term postoperative use only ( Table 2) . Among those with long-term postoperative use were 352 receiving high-dose opioids (32.2%) ( Table 1) .
There were 609 (24.5%) patients with episodic preoperative opioid use, and 133 patients (5.3%) with short-term preoperative opioid use. Another 704 (28.3%) had no opioid use in the 7 months before hospitalization. Among patients with no preoperative opioid use, 90 (12.8%) received long-term postoperative opioids ( Table 2) . www.painjournalonline.com 1149
Opioid dosage
Among the 1045 patients with long-term preoperative opioid use, 34.4% received a lower comparative dose postoperatively, and 9.1% discontinued opioids after the perioperative period. However, 44.8% received a higher dose postoperatively, and 11.8% received an equivalent dose. Among patients with episodic preoperative opioid use, 13.0% decreased dosages postoperatively, and 41.4% received no opioids beyond the perioperative interval. However, 41.7% increased cumulative doses after the perioperative interval ( Table 3) .
Predictors of long-term postoperative opioid use
In simple bivariate comparisons between those who did or did not receive long-term postoperative opioids, younger age, urban residence, indication for surgery, complex fusion procedures, preoperative benzodiazepine use, and all opioid-prescribing variables were significantly associated with greater long-term postoperative use ( Table 1) . Long-term postoperative opioid users had higher comorbidity scores (0.62 vs 0.53, P 5 0.009). In regression models, 21 patients with missing age data were excluded. In our first logistic regression model, excluding opioid Table 4) . Any preoperative use of benzodiazepines was also significant (OR 1.49; 95% CI 1.20-1.85). Patient sex and urban residence were not statistically significant. Increasing age was monotonically associated with lower risk of long-term opioid use, and increasing Charlson comorbidity score was monotonically associated with increasing risk. Complex fusion procedures were no longer associated with long-term opioid use after adjustment for other factors. The AUC was 0.82.
In our second regression model, incorporating opioid dose information, patient demographics, urban or rural residence, and surgical indication were not independently associated with longterm postoperative opioid use ( Table 5) . Preoperative long-term opioid use remained a significant independent predictor of longterm postoperative use (OR 1.68, 95% CI 1.19-2.34), but the opioid dose variables now showed the strongest associations, in dose-response fashion. The strongest predictor was cumulative opioid dose in the 7 months before surgery. There was a monotonic increase in the odds of long-term postoperative use with increasing preoperative dose, with OR 15.47 (95% CI 8.53-28.06) in the highest quartile (cumulative doses .8100 MMEs in the previous 7 months, or a mean daily dose .39 MME) ( Table 4) . Even after adjusting for cumulative preoperative opioid dose, the total MME prescribed in the 30-day immediate postoperative period remained significantly associated with long-term opioid use, again in dose-response fashion. In the highest quartile (cumulative dose .3300 MMEs, or a mean daily dose .110 MME), the OR was 7.96 (95% CI 4.25-14.91).
The number of opioid prescribers in the 30-day immediate postoperative period was also significantly associated with odds of long-term opioid use, even after adjustment for the dosing variables, in a "dose-response" fashion. After adjusting for opioid dosing and numbers of prescribers, preoperative benzodiazepine use was no longer associated with the probability of long-term opioid use. The Hosmer-Lemeshow goodness-of-fit index for this model was acceptable at 0.85, and the AUC improved to 0.90.
Discussion
More patients received long-term opioids after spinal fusion surgery than before surgery. Most patients receiving long-term preoperative opioids continued, and 57% maintained the same dose or increased their dose by more than 10% after the perioperative interval. Furthermore, almost 13% of patients who received no preoperative opioids ended up receiving long-term postoperative opioids. The strongest independent predictors of long-term postoperative opioid use were the cumulative preoperative dose and the cumulative dose of opioids prescribed in the immediate postoperative (30 days postdischarge) interval.
Our findings are consistent with other studies indicating that long-term opioid use is common for both before and after lumbar surgery, and that preoperative long-term opioid use is a powerful predictor of long-term postoperative use. 4, 12 Our data further suggest the importance of both the cumulative preoperative dose and the cumulative dose in the immediate postoperative period. The latter may argue for devising anesthetic and operative techniques that minimize postoperative opioid use, 13, 19 along with greater use of nonpharmacologic and nonopioid medication strategies for pain management. 29 Strategies to help patients taper opioids in the immediate postoperative period and attention to the amount of opioids prescribed are also likely to be helpful. Table 3 Postoperative change from cumulative preoperative opioid dose among long-term and episodic preoperative opioid users.* Other investigators have noted that presurgical opioid use predicts several other adverse outcomes, including worse surgical site pain, increased hospital length of stay, delayed return to work, greater surgical complications, and adverse functional outcomes. 2, 5, 20, 21 Together with the increased likelihood of long-term opioid use, and the paucity of evidence for efficacy of long-term opioids, 11 these findings suggest that minimizing long-term opioids for back pain may be important. An association of preoperative opioid use with anxiety and depression also suggests that addressing mood disorders may be important in minimizing opioid use. 3 Surgical patients in general seem often to receive excessive postoperative opioid prescriptions, exceeding requirements for analgesia. 6, 18, 21 In a study of women after cesarean section, the quantity of opioids prescribed exceeded the amount consumed by a substantial margin. Smaller opioid prescriptions were associated with lower consumption, but no worse pain scores or satisfaction. 6 Our findings suggest that minimizing the postoperative dose may also help to reduce the likelihood of long-term use. Our data further suggest that minimizing the number of opioid prescribers in the perioperative period may help minimize this risk, a concern noted with other orthopedic procedures. 26 Our results, and others, indicate that discontinuation of longterm opioids after spinal fusion surgery is not the norm. One explanation would be that many patients do not achieve the expected pain relief from surgery. However, the fact that preoperative opioid use is a major predictor of long-term postoperative use suggests that opioid dependence may be equally or more important, making postoperative discontinuation or dose reduction more difficult. Patients considering fusion surgery for degenerative conditions should be informed that discontinuation of long-term opioid medications is an unlikely result.
Our study has the advantage of representing a true populationbased sample, regardless of insurance coverage or sources of payment. Use of the PDMP assured identification of all prescriptions filled, even with insurance changes or out-ofpocket payments. This measure of opioid use does not depend on patient recall or continuous insurance coverage.
However, there are important limitations as well. We cannot know whether patients consumed the medications they received. Patient's race and ethnicity are not routinely collected with consistent methods. Controlled prescriptions not filled by a licensed Oregon outpatient pharmacy were not captured in the PDMP. We had no information on inpatient opioid prescribing and have not characterized the impact of individual clinician prescribing habits. The definitions of long-term postoperative opioid use are not standardized, although our results are consistent with studies using other definitions. In 2014, Oregon had relatively high use of prescription opioids compared with most other states, 9 and we cannot know how well our results generalize to other states.
In summary, lumbar fusion surgery infrequently reduced the use of opioid therapy postoperatively, especially among those receiving long-term opioids preoperatively. Among opioid-naive patients undergoing surgery, there was a substantial risk of initiating long-term opioid use. Patients should be well informed and have realistic expectations regarding opioid use when considering lumbar fusion surgery. Clinicians treating patients with back pain may need to give greater attention to minimizing long-term opioid use; addressing mood disorders; minimizing postoperative opioid use; and minimizing numbers of opioid prescribers in the perioperative setting. In predicting prolonged postoperative opioid use, previous prescription opioid exposure may be more important than patient characteristics or surgical complexity and is a factor that clinicians control. 
